RecruitingPhase 3NCT04269902
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Sponsor: National Cancer Institute (NCI)
Aberdeen, WA · Bellevue, WA · Bellingham, WA · +621 more sites